We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




New Robotic Solution Enhances Workflow Within Compact Footprint

By LabMedica International staff writers
Posted on 19 Jan 2015
An advance in compact robotic laboratory automation solutions, a new instrument consolidates sample management for chemistry and immunoassay testing and achieves some of the workflow benefits of automation without the space or budget associated with a track-based solution.

Siemens Healthcare Diagnostics of Siemens Healthcare (Frimley, UK), a leader in medical imaging, laboratory diagnostics, medical information technology, and hearing aids, has unveiled the VersaCell X3, featuring increased analytical capacity through a single sample interface with three-instrument connectivity. More...
The one-touch sample management empowers laboratories to advance workflow capabilities and streamline processes to meet their needs. With advanced sorting capabilities, the VersaCell X3 can improve the pre- and post-analytical process and reduce operator hands-on-time.

A priority drawer provides 8 new STAT positions and frees up 50 sample positions for routine processing, increasing sample routing flexibility. Its signature robotic arm delivers individual samples to connected analyzers to help drive towards a predictable turnaround time. The inclusion of a new docking plate reduces service intervention time for all connected systems, supporting uptime so laboratories can deliver timely results to clinicians. Further data consolidation is achievable through a connection to Siemens’ “CentraLink Data Management System.”

“The VersaCell X3 is a new design which provides enhanced capabilities and a harmonized look and feel across our next generation of solutions,” said Catherine Spurgeon, marketing manager for Automation, Siemens Healthcare Diagnostics, “In line with our commitment to continuously advance workflow capabilities, some of our existing VersaCell Systems can be upgraded with the VersaCell X3 Expansion Pack.” She added, “This will enable labs to connect up to three Siemens systems and improve the operator experience with new software and advanced sorting capabilities on their existing VersaCell solution. The VersaCell X3 complements the recent launch of the Siemens Aptio Automation track-based solution, designed for medium- to very high-volume laboratories. We are delighted that the first UK installation has now taken place.”

Related Links:

Siemens Healthcare



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.